Euclidean Capital

Euclidean Capital

Euclidean Capital

FutureShift

How to choose the right DNA kit for you: MyHeritage, 23andMe, AncestryDNA, and more

$82,500,000 Venture capital (Series F)
SiliconANGLE

Genetic testing company 23andMe raises $82.5M from Sequoia and NewView Capital

TechCrunch

23andMe raises $82.5 million in new funding

neurons.AI

Dascena Presents Poster Highlighting Machine Learning Approach to Predict Acute Heart Failure …

$71,500,000 Venture capital (Series B)
FinSMEs

A2 Biotherapeutics Closes $71.5M Series B Funding

CNET

Best DNA test in 2020: 23andMe vs. AncestryDNA and more

neurons.AI

ASAPP Selects Flexential® to Support its Research Computing Power Needs for Artificial Intelligence

Tech Insider

Apple, Google, 23andMe, and others are fighting COVID-19, from wearables to faster CT scans to contact tracing

the home of AI info

AI-Based Research-Driven Company ASAPP Raises $185 Million

the home of AI info

AI-Based Research-Driven Company ASAPP Raises $185 Million

the home of AI info

Dascena raises $50M in Series A round, publishes data on machine learning in sepsis prediction

Crunchbase News

ASAPP Gets $185M In Series B Round 

$50,000,000 Venture capital (Series B)
the home of AI info , Pulse 2.0

Dascena Secures $50M Series B To Improve Patient Outcomes

Crunchbase News

Dascena Secures $50M Series B To Improve Patient Outcomes

$185,000,000 Venture capital (Series B)
the home of AI info , FinSMEs , Pulse 2.0

Artificial Intelligence Firm ASAPP Completes $185 Million in Series B Investment to Radically …

the home of AI info

Artificial Intelligence Firm ASAPP Completes $185 Million in Series B Investment to Radically …

FinSMEs

Dascena Closes $50M Series B Funding

the home of AI info

Dascena Announces Publication of Prospective Study Evaluating Effect of its Machine Learning …

the home of AI info

Dascena Announces Publication of Prospective Study Evaluating Effect of its Machine Learning …

Xconomy

Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More